Lucis Secures $17.3 Million in Latest Series A Funding Round

Lucis secured $17.3 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

Lucis Raises $17.3 million in Funding

YC-backed French preventive health platform Lucis is a Digital Health company.

Investors Behind the Funding

The round was backed by Singular - EU-Startups. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Lucis operates in Healthcare & Life Sciences. YC-backed French preventive health platform Lucis's Series A round shows investors are still backing digital health platforms with real scale narratives. At $17M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

The company is expected to use the new capital to expand its platform, support customers, and continue scaling in Healthcare & Life Sciences.

Looking Ahead

YC-backed French preventive health platform Lucis raises €17.3 million Series A led by Singular - EU-Startups

Source reference: original announcement/article.